CTRI/2023/08/056661
Completed
未知
A survey to evaluate the acceptability and perceived usability and appeal, assessed during a single interaction, of a smartphone application on tobacco cessation, in male and female subjects = 18 years of age who are regular smokers or smokeless tobacco users. - NI
FTB COLAB PRIVATE LIMITED0 sites100 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: Z789- Other specified health status
- Sponsor
- FTB COLAB PRIVATE LIMITED
- Enrollment
- 100
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients meeting following inclusion criteria will be eligible for participation in the study:
- •1\. Male and female subjects in the age group \= 18 years.
- •5\. Subjects who are educated and who are able to read, type and understand instructions in English language given in cab read and understand instructions and information given via poster, videos, chatbot and other sections in smartphone application, and be able to give their feedback on the application.
- •6\. Subject having a smartphone Android \- OS Version 9\.0 or above, or iOS – OS Version 11\.0 or above.
- •7\. Subject/ Legally Acceptable Representative (LAR) of the subject willing to sign the informed consent form
- •8\. Interested in learning, knowing and following tips to quit tobacco smoking and/or smokeless tobacco use. 9\. Not participating in any other tobacco cessation interventions study
Exclusion Criteria
- •the give inclusion criteria number 2 and 3\.
- •2\. Subject had cognitive impairment or a substance use disorder (e.g., alcohol, cannabis, and opioid)
- •3\. Subject is a pregnant woman/lactating mother.
- •4\. Individuals with mental health complications that have been managed for less than 6\-months
- •5\. Hearing and/or vision disabilities in receiving intervention assessment such as videos or podcasts
- •6\. Inability to read, type, speak and understand instructions and concepts in English language.
- •7\. Using any other tobacco cessation interventions (including apps or our other intervention studies)
- •8\. Subject who are not willing to spend or follow the protocol procedure.
- •9\. Subject who is illiterate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
ACceptability of long-acting ART in Cognitive ImpAirment (ACACIA)People living with HIV who have a cognitive impairmentMental and Behavioural DisordersISRCTN14933807niversity of Sussex20
Not yet recruiting
Not Applicable
Observational study to evaluate acceptability and bleeding profile with Drospirenone 4 mg, in a regimen of use 24/4 in contraception (Slinda®, Exeltis HealthCare) after six months of use.Z30Contraceptive managementDRKS00025993Exeltis Healthcare300
Not yet recruiting
Not Applicable
Observational study to evaluate the acceptability and bleeding profile with Drospirenone 4 mg, in a regimen of use 24/4 in contraception (Slinda®) including patient who have been taken Slinda® for at least 5 cycles of use during breastfeeding. BreastSlinda® Study.DRKS00028438Exeltis Poland Sp.zo.o.100
Not yet recruiting
Not Applicable
Online survey on the estimation of acceptance of an automatic bladder irrigation systemN40Hyperplasia of prostateDRKS00025489niversitätsklinikum Freiburg, Department Chirurgie, Klinik für Urologie, Sektion für Urotechnologie150
Active, not recruiting
Phase 1
A pilot study of the potential acceptability of vaporised nicotine products for smoking cessation or long-term substitution among smokersTobacco DependenceMental Health - AddictionInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12615000829516The University of Queensland15